Literature DB >> 7128111

Partial purification and characterization of particulate acid phosphatase of Leishmania donovani promastigotes.

R H Glew, M S Czuczman, W F Diven, R L Berens, M T Pope, D E Katsoulis.   

Abstract

1. More than 90% of the total acid phosphatase activity in a sonicate of L. donovani promastigotes is contained in a particulate fraction (200,000 X g 30 min). The enzyme can be quantitatively extracted and solubilized with the aid of Triton X-100 (0.2 g/100 ml) and purified over 200-fold with 54% yield by chromatography on DEAE-Sephadex, QAE-Sephadex, Sepharose 4B and concanavalin-A Sepharose. 2. The phosphatase is a true acid hydrolase (pH optimum, 5.0-5.5) and has a rather broad substrate specificity; it will catalyze the hydrolysis of 4-methylumbelliferylphosphate, thymolphthalein diphosphate, pyridoxal phosphate, fructose 1,6-diphosphate, glucose 6-phosphate, glucose 1-phosphate, ADP and AMP. 3. It is a large (170,000 daltons in the presence of Triton X-100), stable and acidic enzyme (pI = 4.1) that has the electrophoretic mobility of a type zero or type 1 isoenzyme in acid (pH 4.3) polyacrylamide gels. 4. The enzyme is inhibited by sodium fluoride, 2-mercaptoethanol and mumolar amounts of a number of polyanionic molybdenum and heavy metal complexes that include the following: [C(NH2)3]4[(C3H7O3PO3)2Mo5O15] X 3H2O, [C(NH2)3]2[(C6H5)2AsMo4O15H] X H2O, (NH4)4[SiMo12O40] X H2O and (NH4)6[P2Mo18O62] X 9H2O. 5. L. donovani promastigotes contain very low levels of 10 other acid pH optimum hydrolytic enzymes, with the exception of modest levels of alpha-fucosidase.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7128111     DOI: 10.1016/0305-0491(82)90510-7

Source DB:  PubMed          Journal:  Comp Biochem Physiol B        ISSN: 0305-0491


  15 in total

1.  Cryptosporidium parvum: identification and characterization of an acid phosphatase.

Authors:  María Magdalena Aguirre-García; Pablo C Okhuysen
Journal:  Parasitol Res       Date:  2007-01-25       Impact factor: 2.289

Review 2.  Biochemistry of the Leishmania species.

Authors:  R H Glew; A K Saha; S Das; A T Remaley
Journal:  Microbiol Rev       Date:  1988-12

3.  Acid phosphatase activity of virulent and avirulent clones of Leishmania donovani promastigotes.

Authors:  K Katakura; A Kobayashi
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

4.  Involvement of the macrophage mannose-6-phosphate receptor in the recognition of Leishmania mexicana amazonensis.

Authors:  E M Saraiva; A F Andrade; W de Souza
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

5.  Acid phosphatase activity in Coxiella burnetii: a possible virulence factor.

Authors:  O G Baca; M J Roman; R H Glew; R F Christner; J E Buhler; A S Aragon
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  A cyclic nucleotide-independent protein kinase in Leishmania donovani.

Authors:  S Das; A K Saha; N K Mukhopadhyay; R H Glew
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

7.  The association of distinct acid phosphatases with the flagella pocket and surface membrane fractions obtained from bloodstream forms of Trypanosoma rhodesiense.

Authors:  J McLaughlin
Journal:  Mol Cell Biochem       Date:  1986-05       Impact factor: 3.396

8.  Characterization of a phosphomonoesterase from Brucella abortus.

Authors:  A K Saha; N K Mukhopadhyay; J N Dowling; T A Ficht; L G Adams; R H Glew
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

9.  Leishmania mexicana promastigotes secrete a protein tyrosine phosphatase.

Authors:  Alma R Escalona-Montaño; Daniel Pardavé-Alejandre; Rocely Cervantes-Sarabia; Patricia García-López; Manuel Gutiérrez-Quiroz; Laila Gutiérrez-Kobeh; Ingeborg Becker-Fauser; Maria M Aguirre-García
Journal:  Parasitol Res       Date:  2010-04-20       Impact factor: 2.289

10.  Resistance of leishmanial phosphatases to inactivation by oxygen metabolites.

Authors:  A K Saha; S Das; R H Glew; M Gottlieb
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.